Doximity (DOCS) Q3 Earnings and Revenues Top Estimates

Company Performance - Doximity reported quarterly earnings of $0.45 per share, exceeding the Zacks Consensus Estimate of $0.33 per share, and up from $0.29 per share a year ago, representing an earnings surprise of 36.36% [1] - The company posted revenues of $168.6 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 10.60%, compared to $135.28 million in the same quarter last year [2] - Doximity has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Stock Performance - Doximity shares have increased approximately 8.9% since the beginning of the year, outperforming the S&P 500's gain of 3.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $123.88 million, and for the current fiscal year, it is $1.14 on revenues of $539.15 million [7] - The estimate revisions trend for Doximity is mixed, and future earnings expectations will be influenced by management's commentary during the earnings call [3][4] Industry Context - The Medical Services industry, to which Doximity belongs, is currently ranked in the bottom 34% of over 250 Zacks industries, which may impact stock performance [8] - Another company in the same industry, NeueHealth, is expected to report a quarterly loss of $2.29 per share, indicating challenges within the sector [9]